LIFELINE THERAPEUTICS, INC. SCHEDULES SECOND QUARTER EARNINGS CONFERENCE CALL AND WEBCAST DENVER, Colorado -- Lifeline Therapeutics, Inc. ("Lifeline" or the "Company") (OTCBB: LFLT), maker of Protandim®, will hold a conference call on Monday, February 13, 2006 at 8:00 a.m. MST (10:00 a.m.
DR. LARRY GOLD JOINS LIFELINE THERAPEUTICS, INC. SCIENTIFIC ADVISORY BOARD DENVER, Colorado -- Lifeline Therapeutics, Inc. ("Lifeline" or the "Company") (OTCBB: LFLT), maker of Protandim®, announced today that Larry Gold, Ph.D., has joined its Scientific Advisory Board. Dr.
LIFELINE THERAPEUTICS, INC. FILES AMENDMENT NO. 1 TO SB-2 DENVER, Colorado -- Lifeline Therapeutics, Inc. ("Lifeline" or the "Company") (OTCBB: LFLT), maker of Protandim®, today announced that it has filed Form SB-2 Amendment 1 with the Securities and Exchange Commission. The document is a
LIFELINE THERAPEUTICS, INC. ENGAGES TAGLICH BROTHERS, INC. DENVER, Colorado -- Lifeline Therapeutics, Inc. ("Lifeline" or the "Company") (OTCBB: LFLT), maker of Protandim®, today announced that it has engaged Taglich Brothers, Inc. to create and disseminate comprehensive quarterly research reports.
New scientific data demonstrate Protandim® improves the body's natural ability to reduce oxidative stress by increasing activity of antioxidant enzymes
LIFELINE THERAPEUTICS, INC. NAMES GERALD J. HOUSTON CHIEF FINANCIAL OFFICER DENVER, Colo. (Jan. 4, 2006) — Lifeline Therapeutics, Inc. (OTCBB: LFLT), maker of Protandim®, today named Gerald J. ("Jerry") Houston as its chief financial officer (CFO), effective immediately. Former CFO William B.